-
Start Preamble
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) is announcing a tentative schedule of forthcoming meetings of its public advisory committees for 2006. During 1991, at the request of the Commissioner of Food and Drugs (the Commissioner), the Institute of Medicine (the IOM) conducted a study of the use of FDA's advisory committees. In its final report, one of the IOM's recommendations was for the agency to publish an annual tentative schedule of its meetings in the Federal Register. This publication implements the IOM's recommendation.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Theresa L. Green, Advisory Committee Oversight and Management Staff (HF-4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
The IOM, at the request of the Commissioner, undertook a study of the use of the FDA's advisory committees. In its final report in 1992, one of the IOM's recommendations was for FDA to adopt a policy of publishing an advance yearly schedule of its upcoming public advisory committee meetings in the Federal Register; FDA has implemented this recommendation. The annual publication of tentatively scheduled advisory committee meetings will provide both advisory committee members and the public with the opportunity, in advance, to schedule attendance at FDA's upcoming advisory committee meetings. Because the schedule is tentative, amendments to this notice will not be published in the Federal Register. However, changes to the schedule will be posted on the FDA advisory committees' Internet site located at http://www.fda.gov/oc/advisory/default.htm. FDA will continue to publish a Federal Register notice 15 days in advance of each upcoming advisory committee meeting, to announce the meeting (21 CFR 14.20).
The following list announces FDA's tentatively schedule advisory committee meeting for 2006. You may also obtain up-to-date information by calling the Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area).
Start SignatureCommittee Name Tentative Date(s) of Meetings Advisory Committee 10-Digit Information Line Code OFFICE OF THE COMMISSIONER Pediatric Advisory Committee March, June, and November day(s) to be announced. 8732310001 Science Board to the Food and Drug Administration April and November day(s) to be announced. 3014512603 CENTER FOR BIOLOGICS EVALUATION AND RESEARCH Allergenic Products Advisory Committee March 31, September 13. 3014512388 Blood Products Advisory Committee March 9-10, July 13-14, October 26-27. 3014519516 Cellular, Tissue and Gene Therapies Advisory Committee February 9-10, July 13-14, November 2-3. 3014512389 Transmissible Spongiform Encephalopathies Advisory Committee To be announced. 3014512392 Start Printed Page 76059 Vaccines and Related Biological Products Advisory Committee February 17, May 17-18, September 20-21, November 15-16. 3014512391 CENTER FOR DRUG EVALUATION AND RESEARCH Anesthetic and Life Support Drugs Advisory Committee To be announced. 3014512529 Anti-Infective Drugs Advisory Committee To be announced. 3014512530 Antiviral Drugs Advisory Committee To be announced. 3014512531 Arthritis Advisory Committee To be announced. 3014512532 Cardiovascular and Renal Drugs Advisory Committee April 25-26, July 25-26, November 1-2. 3014512533 Dermatologic and Ophthalmic Drugs Advisory Committee To be announced. 3014512534 Drug Safety and Risk Management Advisory Committee February 9-10, May 4-5. 3014512535 Endocrinologic and Metabolic Drugs Advisory Committee January 23, May 3-4, August 23-24, November 8-9. 3014512536 Gastrointestinal Drugs Advisory Committee September and November day(s) to be announced. 3014512538 Nonprescription Drugs Advisory Committee January 23-24. 3014512541 Oncologic Drugs Advisory Committee March 14 (Pediatric Subcommittee), March 15, June 2, September 12-13, December 6-7. 3014512542 Peripheral and Central Nervous System Drugs Advisory Committee March 7-8. 3014512543 Pharmaceutical Science, Advisory Committee for April 13-14 (Clinical Pharmacology Subcommittee), October 18-19 (Clinical Pharmacology Subcommittee), April, May, and October day(s) to be announced. 3014512539 Psychopharmacologic Drugs Advisory Committee To be announced. 3014512544 Pulmonary-Allergy Drugs Advisory Committee January 24. 3014512545 Reproductive Health Drugs, Advisory Committee for May and June day(s) to be announced. 3014512537 CENTER FOR DEVICES AND RADIOLOGICAL HEALTH Device Good Manufacturing Practice Advisory Committee No tentative meeting scheduled. 3014512398 Medical Devices Advisory Committee (Comprised of 18 Panels) Anesthesiology and Respiratory Therapy Devices Panel April 7, October 6. 3014512624 Circulatory System Devices Panel February 16, April 21, June 16, August 18, October 20. 3014512625 Clinical Chemistry and Clinical Toxicology Devices Panel February 22-23, May 24-25, September 7-8, December 6-7. 3014512514 Dental Products Panel February 28, July 25, October 24. 3014512518 Ear, Nose, and Throat Devices Panel February 1-2, April 3-4, June 15-16, August 10-11, October 11-12, December 4-5. 3014512522 Gastroenterology-Urology Devices Panel March 3, May 5, July 21, October 20. 3014512523 General and Plastic Surgery Devices Panel April 27-28, August 24-25, December 4-5. 3014512519 General Hospital and Personal Use Devices Panel February 9-10, June 12-13, September 28-29. 3014512520 Hematology and Pathology Devices Panel April 28, October 20. 3014512515 Start Printed Page 76060 Immunology Devices Panel July 14, November 8. 3014512516 Medical Devices Dispute Resolution Panel Meeting scheduled as needed. 3014510232 Microbiology Devices Panel February 23-24, September 21-22, October 26-27. 3014512517 Molecular and Clinical Genetics Panel April 13-14, October 5-6. 3014510231 Neurological Devices Panel March 2-4, August 3-4, June 5-6, August 28-29, November 13-14. 3014512513 Obstetrics-Gynecology Devices Panel March 27-28, June 5-6, August 28-29, November 13-14. 3014512524 Ophthalmic Devices Panel March 7-8, May 18, July 13-14, September 19-20, November 2-3. 3014512396 Orthopaedic and Rehabilitation Devices Panel February 2-3, July 27-28, October 26-27, December 11-12. 3014512521 Radiological Devices Panel February 7, May 23, September 12, November 7. 3014512526 National Mammography Quality Assurance Advisory Committee August 28. 3014512397 Technical Electronic Product Radiation Safety Standards Committee October 4. 3014512399 CENTER FOR FOOD SAFETY AND APPLIED NUTRITION Food Advisory Committee March 1, May 3, July 12, September 13. 3014510564 CENTER FOR VETERINARY MEDICINE Veterinary Medicine Advisory Committee March 15, October 16. 3014512548 NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH (NCTR) Science Advisory Board to NCTR April day(s) to be announced. 3014512559 Advisory Committee on Special Studies Relating to the Possible Long-Term Health Effects of Phenoxy Herbicides and Contaminants (Ranch Hands) February day(s) to be announced. 3014512560 Dated: December 14, 2005.
Jason Brodsky,
Acting Associate Commissioner for External Relations.
[FR Doc. E5-7645 Filed 12-21-05; 8:45 am]
BILLING CODE 4160-01-S
Document Information
- Published:
- 12/22/2005
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Notice.
- Document Number:
- E5-7645
- Pages:
- 76058-76060 (3 pages)
- PDF File:
- e5-7645.pdf